Free press releases distribution network?

Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Heiko Niessen, Boehringer-Ingelheim to Present at GTC’s Biomarker Europe Summit on October 9-10, Berlin, Germany - Heiko Niessen, Principal Translational Expert & Team Leader of Clinical Imaging at Boehringer-Ingelheim Will Give a Presentation at GTC’s Biomarker Europe Summit on October 9 10, 2013 in Berlin, Germany - GTCbio.com
Heiko Niessen, Boehringer-Ingelheim to Present at GTC’s Biomarker Europe Summit on October 9-10, Berlin, Germany

 

PRZOOM - /newswire/ - Monrovia, CA, United States, 2013/08/20 - Heiko Niessen, Principal Translational Expert & Team Leader of Clinical Imaging at Boehringer-Ingelheim Will Give a Presentation at GTC’s Biomarker Europe Summit on October 9 10, 2013 in Berlin, Germany - GTCbio.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Heiko Niessen, Principal Translational Expert & Team Leader of Clinical Imaging at Boehringer-Ingelheim, will give a presentation on “How to Select Imaging Biomarkers for Clinical Development” at GTC’s Biomarker Europe Summit on October 9 10, 2013 in Berlin, Germany

Translational medicine has an important function in the transition of projects from preclinical research into clinical development. In this phase preclinical animal models and first studies in healthy subjects or patients are used to generate first evidence of pharmacological response, to improve confidence in targets and drug candidates. Biomarkers obtained from translation imaging methods are an important part in this process between late stage research and early clinical development program to foster and build hypothesis about the mechanism, to test the clinical concept, to differentiate programs with similar clinical outcome, to support go/no-go decisions, and to de-risk large investments. However, in most cases it is not clear which imaging biomarker is best suited for the development program, e.g. which biomarker is most sensitive to disease progression and therapeutic response or most easy to implement in multi-center trials. In this contribution, Dr. Niessen will present examples of translational imaging biomarkers and the assessment and qualification of imaging biomarkers. Specifically, he will address the following points:

• What is the value of imaging biomarkers?
• How to translate and back-translate?
• What do we learn from competitor trials?
• How to qualify new/emerging imaging biomarkers?

Heiko G. Niessen, Ph.D., Principal Translational Medicine Expert for Clinical Imaging leads the Clinical Imaging Team within Global Translational Medicine of Boehringer-Ingelheim Pharma. His team develops and enables translational and clinical imaging strategies for early and late development programs.

GTC’s Biomarker Europe Summit 2013 will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, companion diagnostics, next-generation sequencing technologies, regulatory and reimbursement issues and companion diagnostics.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Heiko Niessen, Boehringer-Ingelheim to Present at GTC’s Biomarker Europe Summit on October 9-10, Berlin, Germany

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  MagLar, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today